Programmed cell death-1 (PD-1) is a cell surface immune checkpoint found on effector T cells, while its ligand, PD-L1, can be expressed by glioblastoma cells, with elevated PD-L1 being associated with poor overall survival in glioblastoma patients, independent of other factors (70–72). Here, CD274 is linked to glioblastoma.